Blog Posts

Defending Market Share in Pharma

Posted by | Fuld & Company

Pharmaceutical firms frequently need to defend their market position against rivals’ competitive strategy. Threats to leading therapies can come in many forms:

  • A structurally similar compound or generic variant is entering the market, aiming to compete with your brand on efficacy, safety, or price
  • A drug with a new mechanism of action has generated considerable excitement, and patients are expected to switch to the novel drug
  • An established product in a related indication may be moving into your market due to a label expansion
  • An existing competitor has begun targeting your product with negative claims

Competitive intelligence (CI) and strategic planning provide pharmaceutical firms with actionable counter-measures to protect market share, retain customers, and minimize the impact of aggressive direct competition.

Tags: , , ,

Related Resources

Read More

The impact of renewable energy on natural gas demand

Is California’s decline in natural gas usage signaling a nationwide trend? California power consumption data for April 2024 shows a […]

Read More

Tesla breaks ground on energy storage plant in China

Tesla Energy is keeping to its word and has broken ground for its second Megafactory in eastern Shanghai, China, ramping […]

Read More

Resurgence in Middle Market M&A: Insights from DealMAX

The 2024 DealMAX conference, held in Las Vegas and organized by the Association for Corporate Growth (ACG) brought together over […]

Subscribe to our mailing list for our latest updates: